期刊文献+

一例速发型肝素诱导的血小板减少症患者的病例分析

Case analysis of a patient with immediate heparin-induced thrombocytopenia
下载PDF
导出
摘要 1例62岁女性患者因下肢动脉栓塞收入院,入院第7天行手术,术后给予肝素钠微量泵泵入抗凝,尿激酶微量泵泵入溶栓,继续降脂、保肝、抗贫血治疗。启动肝素用药24 h内血小板计数从330×10^9/L下降至82×10^9/L,最低值为48×10^9/L。停用肝素后给予阿加曲班替代抗凝治疗,患者血小板计数3 d后升高至正常范围。根据APTT水平调整阿加曲班注射液泵速,持续泵入。下肢动脉栓塞病情加重未缓解。患者行截肢手术,术后使用阿司匹林抗血小板,利伐沙班维持抗凝治疗。患者病情稳定,8 d后出院。 A 62-year-old female patient was admitted to the hospital for lower extremity arterial embolization.The patient underwent surgery on the 7 th day after admission.Heparin sodium micro pump was used for anticoagulation,urokinase micropump for thrombolysis,and lipid-lowering,hepatoprotective and anemia treatments were continued.The platelet count decreased from 330×10^9/L to 82×10^9/L within 24 hours after starting heparin administration,and the lowest value was 48×10^9/L.After heparin was stopped,argatroban was given instead,then the platelet count increased to the normal range after 3 days.The pump speed of argatroban injection was adjusted according to the APTT level and the pumping was continued.The exacerbation of lower extremity arterial embolism was not relieved.Amputation surgery was conducted.Aspirin was used for antiplatelet postoperatively,and rivaroxaban was maintained for anticoagulant therapy.The patient was stable,and was discharged after 8 days.
作者 王可 褚燕琦 赵雯 闫素英 WANG Ke;CHU Yan-qi;ZHAO Wen;YAN Su-ying(Depanment of Pharmacy,Xuanwu Hospital of Cap­ital Medical University,Beijing 100053,China;National Clinical Research Center for Geriatric Disorders,Beijing 100053,China;Department of Pharmacy,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,China)
出处 《实用药物与临床》 CAS 2020年第1期82-85,共4页 Practical Pharmacy and Clinical Remedies
基金 北京市卫生和计划生育委员会“老年重大疾病关键技术研究”(PXM2018_026283_000002)
关键词 肝素 速发型 血小板减少症 阿加曲班 Heparin Immediate onset Thrombocytopenia Argatroban
  • 相关文献

参考文献3

二级参考文献20

  • 1Fareed J, Jeske WP, Small-molecule direct antithrombins: argatroban. Best Pract Res Clin Haematol, 2004, 17 ( 1 ) : 127-138.
  • 2Kam PC, Kaur N, Thong CL. Direct thrombin inhibitors: pharmacology and clinical relevance. Direct thrombin inhibitors: pharmacology and clinical relevance. Anaesthesia, 2005,60 ( 6 ) : 565-574.
  • 3Menajovsky LB. Heparin-induced thrombocytopenia: clinical anifestations and management strategies. Am J Med, 2005, 118(Suppl 8A) :21S-30S.
  • 4Serebruany MV, Malinin AI, Serebruany VL Argatroban, a direct thrombin inhibitor for heparin-indueed thrombocytopaenia: present and future perspectives, Expert Opin Pharmacother, 2006,7( 1 ) :81-89,
  • 5Levine RL, Hursting MJ, McCollum D, Argatroban therapy in heparin-induced thrombocytopeina with hepatic dysfunction. Chest, 2006, 129(5) :1167-1175.
  • 6Arnold RJ, Kim R, Tang B. The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment. Cardiol Rev, 2006, 14( 1 ) :7-13.
  • 7Lewis BE, Matthai WH Jr, Cohen M, et al. Argatroban anticoagulation during pereutanceous coronary intervention in patients with heparin-induced thrombocytopenia. Catheter Cardiovase I nterv, 2002,57 ( 2 ) : 177-184.
  • 8Jang IK, Lewis BE, Matthai WH Jr, et al. Argatroban anticoagulation in conjunction with glycoprotein Ⅱ b/Ⅲ a inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study. J Thromb Thrombolysis, 2004,18( 1 ) :31-37.
  • 9Itoh T, Nonogi H, Miyazaki S, et al. Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty: a prospective randomized pilot study. Circ J, 2004,68(7) :615-622.
  • 10Kawamata T, Okada Y, Kawashima A, et al. Carotid tissue levels of argatroban after direct local delivery during carotid endarterectomy to prevent perioperative cerebral embolism. Neurosurgery, 2005,56(5) :913-918.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部